Ginsenoside Rh1 Alleviates HK‐2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 3401067
Abstract
Background. Cisplatin is widely used in the treatment of malignant patients; however, its adverse nephrotoxic effects limit its clinical use. Ginsenoside Rh1 is a main component of ginseng and has many pharmaceutical effects, including immunomodulatory effects. Objective. The objective of this research is to assess the effects of ginsenoside Rh1 on a cisplatin‐induced HK‐2 injury model and to study its potential effect mechanisms. Methods. HK‐2 cell vitality was assessed via Cell Counting Kit‐8 (CCK‐8) assay. Carboxyfluorescein succinimidyl ester/propidium iodide (CFSF/PI) staining was used to detect the apoptosis of HK‐2 cells. ROS expression was detected by DCFDA. The expressions of JNK, p53, caspase‐3, Bax, and NGAL were detected by western blot. Results. Ginsenoside Rh1 was found to increase the vitality of HK‐2 cells and inhibit ROS production and the apoptosis of HK‐2 cells in a cisplatin‐induced injury model. Ginsenoside Rh1 was found to inhibit the expression of JNK, p53, caspase‐3, Bax, and NGAL in a cisplatin‐induced injury model. Conclusion. Ginsenoside Rh1 alleviated HK‐2 apoptosis in a cisplatin‐induced injury model by inhibiting ROS production and the JNK/p53 pathway. Ginsenoside Rh1 may be a promising drug for the alleviation of cisplatin‐induced nephrotoxicity in malignant patients.Keywords
This publication has 27 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cellsKidney International, 2011
- Anti‐inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide‐stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase‐1 expressionJournal of Neurochemistry, 2010
- Update on the diagnosis and management of acute kidney injuryInternational Journal of Nephrology and Renovascular Disease, 2010
- siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney InjuryJournal of the American Society of Nephrology, 2009
- Cisplatin Cytotoxicity of Auditory Cells Requires Secretions of Proinflammatory Cytokines via Activation of ERK and NF-κBJournal of the Association for Research in Otolaryngology, 2007
- Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activityAmerican Journal of Physiology-Renal Physiology, 2004
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003
- Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent PathwaysThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometryCytometry, 1997